{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:12:18Z","timestamp":1759680738792,"version":"build-2065373602"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,5]]},"DOI":"10.7759\/cureus.93876","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:42:04Z","timestamp":1759678924000},"source":"Crossref","is-referenced-by-count":0,"title":["Esketamine in a Patient With Major Depressive Disorder and Polysubstance Use: A Case Report"],"prefix":"10.7759","author":[{"given":"Abdelazim","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahida","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sona","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.01.141","article-title":"Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: systematic review and meta-analysis","volume":"266","author":"Hunt GE","year":"2020","unstructured":"Hunt GE, Malhi GS, Lai HM, Cleary M. Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: systematic review and meta-analysis. J Affect Disord. 2020, 266:288-304. 10.1016\/j.jad.2020.01.141","journal-title":"J Affect Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaf027","article-title":"Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study","volume":"28","author":"Zaki N","year":"2025","unstructured":"Zaki N, Chen LN, Lane R, et al.. Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study. Int J Neuropsychopharmacol. 2025, 28:pyaf027. 10.1093\/ijnp\/pyaf027","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.01.017","article-title":"Ketamine for the treatment of addiction: evidence and potential mechanisms","volume":"142","author":"Ivan Ezquerra-Romano I","year":"2018","unstructured":"Ivan Ezquerra-Romano I, Lawn W, Krupitsky E, Morgan CJ. Ketamine for the treatment of addiction: evidence and potential mechanisms. Neuropharmacology. 2018, 142:72-82. 10.1016\/j.neuropharm.2018.01.017","journal-title":"Neuropharmacology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2021.21030277","article-title":"Adjunctive ketamine with relapse prevention-based psychological therapy in the treatment of alcohol use disorder","volume":"179","author":"Grabski M","year":"2022","unstructured":"Grabski M, McAndrew A, Lawn W, et al.. Adjunctive ketamine with relapse prevention-based psychological therapy in the treatment of alcohol use disorder. Am J Psychiatry. 2022, 179:152-62. 10.1176\/appi.ajp.2021.21030277","journal-title":"Am J Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102283","article-title":"Ketamine, esketamine, and arketamine: their mechanisms of action and applications in the treatment of depression and alleviation of depressive symptoms","volume":"12","author":"Kawczak P","year":"2024","unstructured":"Kawczak P, Feszak I, B\u0105czek T. Ketamine, esketamine, and arketamine: their mechanisms of action and applications in the treatment of depression and alleviation of depressive symptoms. Biomedicines. 2024, 12:2283. 10.3390\/biomedicines12102283","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419540-esketamine-in-a-patient-with-major-depressive-disorder-and-polysubstance-use-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:42:04Z","timestamp":1759678924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419540-esketamine-in-a-patient-with-major-depressive-disorder-and-polysubstance-use-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,5]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.93876","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,5]]}}}